Testing effectiveness (Phase 2)Not Yet RecruitingNCT06678399
What this trial is testing
Phase 1B/2 Clinical Trial Assessing the Safety, Tolerability and Preliminary Efficacy of the Intravenous Administration of Allogeneic Placental Mesenchymal Cells for the Preemptive Treatment of Patients At Risk for Acute Kidney Injury Following Cardiac Surgery
Who this might be right for
Preemptive Therapy of Patients At Risk for Acute Kidney Injury Following Cardiac Surgery
Kelifarma 91